Barry, H, Hardiman, O, Healy, DG, Keogan, M, Moroney, J, Molnar, PP, Cotter, DR, Murphy, KC (2011) Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. British Journal of Psychiatry 199, 508–509.
Bebbington, P, Nayani, T (1995) The psychosis screening questionnaire. International Journal of Methods in Psychiatric Research 5, 11–19.
Beck, K, Lally, J, Shergill, SS, Bloomfield, MAP, MacCabe, JH, Gaughran, F, Howes, OD (2015) Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis. British Journal of Psychiatry 206, 164–165.
Benros, ME, Eaton, WW, Mortensen, PB (2014) The epidemiologic evidence linking autoimmune diseases and psychosis. Biological Psychiatry 75, 300–306.
Coutinho, E, Harrison, P, Vincent, A (2014) Do neuronal autoantibodies cause psychosis? A neuroimmunological perspective. Biological Psychiatry 75, 269–275.
Dalmau, J, Gleichman, AJ, Hughes, EG, Rossi, JE, Peng, X, Lai, M, Dessain, SK, Rosenfeld, MR, Balice-Gordon, R, Lynch, DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurology 7, 1091–1098.
de Witte, LD., Hoffmann, C., van Mierlo, HC, Titulaer, MJ, Kahn, RS, Martinez-Martinez, P (2015) Absence of N-methyl-D-aspartate receptor IgG autoantibodies in schizophrenia: the importance of cross-validation studies. JAMA Psychiatry 72, 731–733.
Deakin, J, Lennox, BR, Zandi, MS (2014) Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis. Biological Psychiatry 75, 284–291.
Eaton, WW, Byrne, M, Ewald, H, Mors, O, Chen, CY, Agerbo, E, Mortensen, PB (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. American Journal of Psychiatry 163, 521–528.
Ezeoke, A, Mellor, A, Buckley, P, Miller, B (2013) A systematic, quantitative review of blood autoantibodies in schizophrenia. Schizophrenia Research 150, 245–251.
Gresa-Arribas, N, Titulaer, MJ, Torrents, A, Aguilar, E, McCracken, L, Leypoldt, F, Gleichman, AJ, Balice-Gordon, R, Rosenfeld, MR, Lynch, D, Graus, F, Dalmau, J (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. The Lancet Neurology 13, 167–177.
Hacohen, Y, Singh, R, Rossi, M, Lang, B, Hemingway, C, Lim, M, Vincent, A (2015) Clinical relevance of voltage-gated potassium channel-complex antibodies in children. Neurology 85, 967–975.
Hammer, C, Stepniak, B, Schneider, A, Papiol, S, Tantra, M, Begemann, M, Siren, AL, Pardo, LA, Sperling, S, Mohd Jofrry, S, Gurvich, A, Jensen, N, Ostmeier, K, Luhder, F, Probst, C, Martens, H, Gillis, M, Saher, G, Assogna, F, Spalletta, G, Stocker, W, Schulz, TF, Nave, KA, Ehrenreich, H (2014) Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Molecular Psychiatry 19, 1143–1149.
Haussleiter, IS, Emons, B, Schaub, M, Borowski, K, Brüne, M, Wandinger, K-P, Juckel, G (2012) Investigation of antibodies against synaptic proteins in a cross-sectional cohort of psychotic patients. Schizophrenia Research 140, 258–259.
Irani, SR, Alexander, S, Waters, P, Kleopa, KA, Pettingill, P, Zuliani, L, Peles, E, Buckley, C, Lang, B, Vincent, A (2010a) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 133, 2734–2748.
Irani, SR, Bera, K, Waters, P, Zuliani, L, Maxwell, S, Zandi, MS, Friese, MA, Galea, I, Kullmann, DM, Beeson, D, Lang, B, Bien, CG, Vincent, A (2010b) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133, 1655–1667.
Irani, SR, Michell, AW, Lang, B, Pettingill, P, Waters, P, Johnson, MR, Schott, JM, Armstrong, RJ, S Zagami, A, Bleasel, A, Somerville, ER, Smith, SM, Vincent, A (2011) Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Annals of Neurology 69, 892–900.
Kay, SR, Fiszbein, A, Opler, LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.
Kayser, MS, Titulaer, MJ, Gresa-Arribas, N, Dalmau, J (2013) Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurology 70, 1133–1139.
Lang, B, Makuch, M, Moloney, T, Dettmann, I, Mindorf, S, Probst, C, Stoecker, W, Buckley, C, Newton, CR, Leite, MI, Maddison, P, Komorowski, L, Adcock, J, Vincent, A, Waters, P, Irani, SR (2017) Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies. Journal of Neurology Neurosurgery & Psychiatry.
Lennox, BR, Palmer-Cooper, EC, Pollak, T, Hainsworth, J, Marks, J, Jacobson, L, Lang, B, Fox, H, Ferry, B, Scoriels, L, Crowley, H, Jones, PB, Harrison, PJ, Vincent, A (2017) Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study. Lancet Psychiatry 4, 42–48.
Masdeu, JC, Gonzalez-Pinto, A, Matute, C, Ruiz De Azua, S, Palomino, A, De Leon, J, Berman, KF, Dalmau, J (2012) Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. American Journal of Psychiatry 169, 1120–1121.
McGuffin, P, Farmer, A, Harvey, I (1991) A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry 48, 764–770.
Paterson, RW, Zandi, MS, Armstrong, R, Vincent, A, Schott, JM (2014) Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. Journal of Neurology Neurosurgery and Psychiatry 85, 625–630.
Pathmanandavel, K, Starling, J, Merheb, V, Ramanathan, S, Sinmaz, N, Dale, RC, Brilot, F (2014) Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children. Biological Psychiatry 23, 00547–2.
Pearlman, DM, Najjar, S (2014) Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Schizophrenia Research 157, 249–258.
Pettingill, P, Kramer, HB, Coebergh, JA, Pettingill, R, Maxwell, S, Nibber, A, Malaspina, A, Jacob, A, Irani, SR, Buckley, C, Beeson, D, Lang, B, Waters, P, Vincent, A (2015) Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization. Neurology 84, 1233–1241.
Pollak, TA, McCormack, R, Peakman, M, Nicholson, TR, David, AS (2014) Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Psychological Medicine 44, 2475–2487.
Rhoads, J, Guirgis, H, McKnight, C, Duchemin, AM (2011) Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia. Schizophrenia Research 129, 213–214.
Somers, KJ, Lennon, VA, Rundell, JR, Pittock, SJ, Drubach, DA, Trenerry, MR, Lachance, DH, Klein, CJ, Aston, PA, McKeon, A (2011) Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity. Journal of Neuropsychiatry & Clinical Neuroscience 23, 425–433.
Steiner, J, Walter, M, Glanz, W, Sarnyai, Z, Bernstein, HG, Vielhaber, S, Kastner, A, Skalej, M, Jordan, W, Schiltz, K, Klingbeil, C, Wandinger, KP, Bogerts, B, Stoecker, W (2013) Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry 70, 271–278.
Tsutsui, K, Kanbayashi, T, Tanaka, K, Boku, S, Ito, W, Tokunaga, J, Mori, A, Hishikawa, Y, Shimizu, T, Nishino, S (2012) Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry 12, 37.
Wandinger, KP, Saschenbrecker, S, Stoecker, W, Dalmau, J (2011) Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. Journal of Neuroimmunology 231, 86–91.
Wright, P, Laing, P, Donaldson, PT, Murray, RM (1999) Schizophrenia: the teratogenic antibody hypothesis. In Psychiatry, Psychoimmunology, and Viruses (ed. Müller, N.), pp. 89–99. Springer Vienna: Vienna.
Zandi, MS, Irani, SR, Lang, B, Waters, P, Jones, PB, McKenna, P, Coles, AJ, Vincent, A, Lennox, BR (2011) Disease-relevant autoantibodies in first episode schizophrenia. Journal of Neurology 258, 686–688.
Zuliani, L, Graus, F, Giometto, B, Bien, C, Vincent, A (2012) Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. Journal of Neurology Neurosurgery and Psychiatry 83, 638–645.